Blincyto and Oedema - a phase IV clinical study of FDA data

Summary:

Oedema is reported as a side effect among people who take Blincyto (blinatumomab), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Cytarabine, and have Acute lymphocytic leukemia (all).

The phase IV clinical study analyzes which people have Oedema when taking Blincyto. It is created by eHealthMe based on reports of 6,058 people who have side effects when taking Blincyto from the FDA, and is updated regularly.

What is Blincyto?

Blincyto has active ingredients of blinatumomab. eHealthMe is studying from 6,058 Blincyto users. Check the latest studies of Blincyto.

What is Oedema?

Oedema (fluid collection in tissue) is found to be associated with 2,183 drugs and 2,311 conditions by eHealthMe. Check the latest studies of Oedema.

On Jul, 20, 2026

6,058 people reported to have side effects when taking Blincyto.
Among them, 20 people (0.33%) have Oedema.

Among these 20 people:

How long have people been on Blincyto when they have Oedema? *

What is the gender of people who have Oedema when taking Blincyto? *

female: 27.78 %
male: 72.22 %

What is the age of people who have Oedema when taking Blincyto? *

What are other drugs people take besides Blincyto? *

What are other side effects people have besides Oedema? *

Fever: 13 people, 65.00%
Thrombocytopenia (decrease of platelets in blood): 5 people, 25.00%
Cytokine Release Syndrome (immediate complication occurring with the use of anti-t cell antibody infusions): 3 people, 15.00%
Death: 3 people, 15.00%
Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 3 people, 15.00%
Herpes Zoster: 2 people, 10.00%
Weight Decreased: 2 people, 10.00%
Blood Lactate Dehydrogenase Increased: 2 people, 10.00%
Myelosuppression (a decrease in the production of blood cells): 2 people, 10.00%
Headache (pain in head): 2 people, 10.00%

What are the existing conditions these people have? *

Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 10 people, 50.00%
B Precursor Type Acute Leukaemia (lymphoid cancer): 5 people, 25.00%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 1 person, 5.00%
Central Nervous System Leukaemia (cancer of central nervous system): 1 person, 5.00%
B-Cell Type Acute Leukaemia (cancer of the white blood cells): 1 person, 5.00%
Acute Leukaemia (blood cancer): 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Blincyto and have Oedema?

- Check whether Oedema is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Blincyto:

Blincyto (6,058 reports)

Oedema treatments and more:

Oedema (78,747 reports)

Browse all side effects of Blincyto:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Oedema:

Oedema (2,183 drugs)

Browse all the conditions that are associated with Oedema:

Oedema (2,311 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on blinatumomab (the active ingredients of Blincyto) and Blincyto (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.